Towards Early and More Specific Diagnosis of Prostate Cancer? Beyond PSA: New Biomarkers Ready for Prime Time

This paper describes the development of PCA3-based molecular urine tests, and we also review the most recent data demonstrating the potential diagnostic and prognostic utilities of PCA3 and the initial findings of the TMPRSS2-ERG gene fusion testing.